IGF2BP2 and metabolic dysfunction-associated steatohepatitis: Furthermore, expression levels of IGF2BP2 were significantly upregulated in the livers of NASH patients, as compared to that in normal subjects (Fig. 2g and h), which was further confirmed by immunochemistry staining (Fig. 2i and j).